← back to search

Adriana Corben

Maimonides Medical Center ·
Area of research
Pathology and Forensic Medicine · Cancer Research
Research interest
Research interests include Breast Lesions and Carcinomas, Breast Cancer Treatment Studies, Breast Implant and Reconstruction, and Heat shock proteins research.
h-index
29
citations
3,001
works
66
NIH funding
primary concept
email

Recent publications

Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation
Nature Communications 2024cited by 26position: middledoi
Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation
Nature Communications 2023cited by 44position: middledoi
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
Nature Communications 2021cited by 33position: middledoi
Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer
Communications Biology 2021cited by 26position: middledoi
Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone
Cell Reports 2020cited by 61position: middledoi
Paradigms for Precision Medicine in Epichaperome Cancer Therapy
Cancer Cell 2019cited by 59position: middledoi
The epichaperome is an integrated chaperome network that facilitates tumour survival
Nature 2016cited by 302position: middledoi
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using <sup>89</sup>Zr-Trastuzumab PET/CT
Journal of Nuclear Medicine 2016cited by 180position: middledoi
Prospective Clinical Trial of <sup>18</sup>F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers
Journal of Nuclear Medicine 2016cited by 62position: middledoi
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype
European Journal of Nuclear Medicine and Molecular Imaging 2015cited by 105position: middledoi
Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
Expert Opinion on Investigational Drugs 2014cited by 172position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gary A. Ulaner · University of Southern California3 papers (2015–2016)Serge K. Lyashchenko · Memorial Sloan Kettering Cancer Center2 papers (2016–2016)Mithat Gönen · Centre de Recherche Épidémiologie et Statistique2 papers (2015–2016)Jason S. Lewis · WinnMed2 papers (2016–2016)Debra A. Goldman · Miriam Hospital2 papers (2015–2016) · 1 papers (2014–2014)Heather L. McArthur · Texas Oncology1 papers (2016–2016)Mark Dunphy · Memorial Sloan Kettering Cancer Center1 papers (2014–2014)Yelena Y. Janjigian · Cancer Clinic1 papers (2014–2014) · 1 papers (2014–2014) · 1 papers (2016–2016)Stephen B. Solomon · Society of Interventional Radiology1 papers (2016–2016)Shanu Modi · Beneficência Portuguesa de São Paulo1 papers (2014–2014)Stefan O. Ochiana · Northeastern University1 papers (2014–2014)Gabriela Chiosis · Memorial Sloan Kettering Cancer Center1 papers (2014–2014)Sarat Chandarlapaty · Organogenesis (United States)1 papers (2016–2016)Shari Goldfarb · Memorial Sloan Kettering Cancer Center1 papers (2016–2016)Joseph P. Erinjeri · Cornell University1 papers (2016–2016)Clifford A. Hudis · American Society of Clinical Oncology1 papers (2015–2015)Maxine S. Jochelson · The Women’s Imaging Center1 papers (2015–2015)